Renamezin capsule

DRUG2 trials

Sponsors

Daewon Pharmaceutical Co., Ltd.

Conditions

Chronic Renal Failure

Phase 4

A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure

CompletedNCT02681952

Daewon Pharmaceutical Co., Ltd.Chronic Renal Failure

Start: 2015-12-31End: 2016-12-31Updated: 2017-07-06

Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.

CompletedNCT02681991

Daewon Pharmaceutical Co., Ltd.Chronic Renal Failure

Start: 2016-01-31End: 2016-09-30Updated: 2017-07-06

Related Papers

Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial

Yonsei Medical Journal2020-12-298 citations

New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study.

2020-07-314 citations